Clinical and molecular epidemiology of chromosome-mediated resistance to third-generation cephalosporins in Enterobacter isolates in eastern France

Clinical Microbiology and Infection

Volumn 6, Issue 7, 2000, Pages 374-382

  Talon, D ^a   Bailly, P ^a   Bertrand, X ^a   Thouverez, M ^a   Mulin, B ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Enterobacter; Molecular epidemiology; Risk factors; Third generation cephalosporin resistance

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BACTERIAL DNA; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA FINGERPRINTING; ENTEROBACTER; ENTEROBACTER INFECTION; ENZYME SYNTHESIS; FEMALE; FRANCE; GENETIC EPIDEMIOLOGY; HOSPITALIZATION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TREATMENT OUTCOME; URINARY TRACT INFECTION; WILD TYPE;

BACTERIA (MICROORGANISMS); ENTEROBACTER;

EID: 0034236215     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2000.00097.x     Document Type: Article

References (49)

1. Predominant pathogens in hospital infections
2. Enterobacterbacteremia: Clinical features and emergence of antibiotic resistance during therapy
3. Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital
4. Entcrobactcr spp. pathogens poised to flourish at the turn of the century
5. A functional classification scheme for β lactamases and its correlation with molecular structure
6. β lactamase of gram-negative bacteria: New challenges for new drugs
7. Concomitant dissemination of three extended-spectrum β lactamases among different Enterobacteriaceae isolated in a French hospital
8. Prospective survey of colonization and infection caused by expanded-spectrum β lactamase-producing members of the family Enterobacteriaceae in an intensive care unit
9. Characterization of ceftriaxone-resistant Enterobacteriaceae: A multicentre study in 26 French hospitals
10. Outbreak of ceftazidime resistance caused by extended-spectrum 13 lactamases at a Massachusetts chronic-care facility
11. Molecular epidemiology of ceftazidime-resistant Enterobacteriaceac from patients on a pediatric oncology ward
12. Clinical and bacteriological study of nosocomial infections due to Enterobacteraerogenes, resistant to imipenem
13. Extended broad-spectrum β lactamases conferring transferable resistance to newer 13 lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility
14. Epidemiological study of an outbreak due to multidrug-resistant Enterobacteraerogenes in a medical intensive care
15. Molecular epidemiology of infections due to Enterobacteraerogenes: Identification of hospital outbreak-associated strains by molecular techniques
16. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition
17. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
18. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam
19. Importation of organisins producing broad-spectrum SHV-group β lactamases into the United Kingdom
20. The National Nosocomial Infections Surveillance System. Evidence of interhospital transmission of extended- spectrum β lactam-resistant Klebsiella pneumoniae in the United States. 1986-93
21. Antibiotic policy: A tool for controlling resistance of hospital pathogens
22. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β lactamase-producing organisms
23. Report of the Comité de L'antibiogramme de la Société Française de Microbiologie
24. Resistance to cefotaxime and seven other β lactams in members of the family Enterobacteriacea: A 3-year survey in France
25. Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed-field gel electrophoresis of genomic restriction fragments
26. Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genuine fingerprinting
27. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
28. Non-parametric estimation from incomplete observations
29. Maximum utilization of the life-table method in analyzing survival
30. A symptomatically efficient rank invariant test procedures (with discussion)
31. Enterobacter cloacae: Bacteremia, epidemiology, and antibiotic resistance
32. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins
33. Clinical consequences of development of resistance to third-generation cephalosporins
34. Clinical implications of multi-drug resistance in the intensive care unit
35. The current and future impact of antimicrobial resistance among nosocomial bacterial pathogens
36. Trends in antibiotic utilization and bacterial resistance: Report of the National Nosocomial Resistance Surveillance Group
37. National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States
38. Prior antimicrobial therapy and resistance of Enterobacter, Citrobacter and Serratia to third-generation cephalosporins
39. Inducible β lactamases: Clinical and epidemiologic implications for use of newer cephalosporins
40. Emergence of resistance during therapy with newer β lactam antibiotics: Role of inducible β lactamases and implications for the future
41. Broad-spectrum β lactam resistance in Enterobacter: Emergence during treatment and mechanisms of resistance
42. β-Lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy
43. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland
44. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
45. Restriction policy and strict monitoring of quinolone usage may decrease resistance in the hospital
46. Effects of requiring prior authorization for selected antimicrobials; expenditures, susceptibilities and clinical outcomes
47. Development of resistance during antibiotic therapy
48. Microbial resistance to newer generation β lactam antibiotics: Clinical and laboratory implications
49. Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients